Associate Director, Computational Biology & Bioinformatics

Obsidian Therapeutics; Bedford (MA); Hybrid; USD 189,000 - 241,500; Full time

Benefits offered by this job

Competitive salary and benefits

Stock options

Generous paid time off

Job summary

Obsidian Therapeutics is seeking an Associate Director with a strong background in computational biology to lead analytical strategies supporting our clinical-stage therapy. This role will oversee computational methodologies, collaborate with multi-disciplinary teams, and contribute significantly to the development of transformative therapies.

Located in Bedford, MA, this hybrid role is integral in ensuring successful outcomes across research initiatives. The position offers competitive salary, benefits, and potential ownership through stock options.

Qualifications

• 3+ years of experience in industry or MS degree with 8+ years of relevant work experience.
• Ability to adapt in a fast-paced environment.
• Experience in cancer genomic data analysis is a plus.

Responsibilities

• Lead efforts in data analysis for translational and discovery research.
• Oversee execution of analyses using sequencing and biological data.
• Communicate analysis results with stakeholders.

Skills

Proficiency with programming languages for bioinformatics analysis

Proficiency with NGS data analysis tools

Proficiency with Unix-based systems

Biostatistical methods

Education

PhD in Computational Biology/Bioinformatics or related field

Tools

Python

R

Git

AWS

Azure

Job description

Obsidian Therapeutics is seeking an Associate Director with a strong background in computational biology to lead analytical strategies supporting our clinical-stage therapy. This role will oversee computational methodologies, collaborate with multi-disciplinary teams, and contribute significantly to the development of transformative therapies.

Located in Bedford, MA, this hybrid role is integral in ensuring successful outcomes across research initiatives. The position offers competitive salary, benefits, and potential ownership through stock options.